Literature DB >> 16458992

Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats.

Bernhard Angermayr1, Marc Mejias, Jorge Gracia-Sancho, Juan Carlos Garcia-Pagan, Jaime Bosch, Mercedes Fernandez.   

Abstract

BACKGROUND/AIMS: The pathophysiological significance of heme oxygenase-1 up-regulation in portal hypertension is not completely understood. In this study, we determined the role of heme oxygenase-1 on oxidative stress, inflammation, angiogenesis, and splanchnic hemodynamics in rats with portal hypertension induced by partial portal vein ligation.
METHODS: Rats were treated with the heme oxygenase inhibitor SnMP or vehicle for 7 days. Then, oxidative stress was quantified by superoxide anion production, and inflammatory response was assessed by immunofluorescence. Expression of angiogenesis mediators was determined by western blotting, and the extent of portosystemic collaterals by radioactive microspheres. Hemodynamic studies were performed by flowmetry.
RESULTS: Oxidative stress was significantly increased in the mesentery of portal hypertensive rats, as compared with sham-operated controls. In portal hypertensive rats, chronic heme oxygenase inhibition (1) potentiated oxidative stress and inflammation, (2) significantly decreased VEGF expression, without modifying the extent of collaterals or the splanchnic neovascularization, and (3) significantly decreased superior mesenteric artery blood flow and portal pressure.
CONCLUSIONS: This study demonstrates that heme oxygenase plays an important (beneficial) role attenuating oxidative stress and inflammation, but it also plays a detrimental role in stimulating VEGF production, and contributing to the development of hyperdynamic splanchnic circulation in rats with portal hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16458992     DOI: 10.1016/j.jhep.2005.09.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  20 in total

Review 1.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

2.  Vascular biology and pathobiology of the liver: Report of a single-topic symposium.

Authors:  Yasuko Iwakiri; Matthew Grisham; Vijay Shah
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

3.  Disruption of the transcription factor Nrf2 promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness upon activation by ambient particulate matter.

Authors:  Marc A Williams; Tirumalai Rangasamy; Stephen M Bauer; Smruti Killedar; Matthew Karp; Thomas W Kensler; Masayuki Yamamoto; Patrick Breysse; Shyam Biswal; Steve N Georas
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.

Authors:  Bernhard Angermayr; Mercedes Fernandez; Marc Mejias; Jorge Gracia-Sancho; Juan Carlos Garcia-Pagan; Jaime Bosch
Journal:  Gut       Date:  2006-07-19       Impact factor: 23.059

5.  The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.

Authors:  M A Aller; I Prieto; S Argudo; F de Vicente; L Santamaría; M P de Miguel; J L Arias; J Arias
Journal:  Int J Inflam       Date:  2010-10-05

Review 6.  Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.

Authors:  Jozef Dulak; Jessy Deshane; Alicja Jozkowicz; Anupam Agarwal
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

7.  (S)-1-α-naphthylmethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712), promotes wound closure by producing VEGF through HO-1 induction in human dermal fibroblasts and mouse skin.

Authors:  Hwa Jin Jang; Konstantin Tsoyi; Young Min Kim; Eun Jung Park; Sang Won Park; Hye Jung Kim; Jae Heun Lee; Ki Churl Chang
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 8.  Physiological significance of heme oxygenase in hypertension.

Authors:  Jian Cao; Kazuyoshi Inoue; Xiaoying Li; George Drummond; Nader G Abraham
Journal:  Int J Biochem Cell Biol       Date:  2008-11-05       Impact factor: 5.085

9.  Pathophysiology of portal hypertension and esophageal varices.

Authors:  Hitoshi Maruyama; Osamu Yokosuka
Journal:  Int J Hepatol       Date:  2012-05-15

10.  Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib.

Authors:  Romain Coriat; Hervé Gouya; Olivier Mir; Stanislas Ropert; Olivier Vignaux; Stanislas Chaussade; Philippe Sogni; Stanislas Pol; Benoit Blanchet; Paul Legmann; François Goldwasser
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.